Implications of HLA-E allele expression and different HLA-E ligand diversity for the regulation of NK cells

Human Immunology

Volumn 61, Issue 11, 2000, Pages 1059-1065

  Maier, Sabine ^a   Grzeschik, Mariola ^a   Weiss, Elisabeth H ^a   Ulbrecht, Matthias ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Inst Anthropologie und Humangenetik   (Germany)

Author keywords

Antigen presentation; HLA E; MHC; NK cells; Peptides

Indexed keywords

HLA ANTIGEN CLASS 1; HLA C ANTIGEN; HLA E ANTIGEN; LIGAND; PEPTIDE;

ALLELE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; CAUCASIAN; CELL SURFACE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION FUNCTION; GENE EXPRESSION REGULATION; GENE FREQUENCY; HUMAN; HUMAN CELL; INHIBITION KINETICS; LYSIS; MOLECULAR INTERACTION; NATURAL KILLER CELL; PLACENTA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

ALLELES; ANTIGENS, CD; ANTIGENS, CD94; CYTOTOXICITY TESTS, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIGANDS; MEMBRANE GLYCOPROTEINS; OLIGOPEPTIDES; RECEPTORS, IMMUNOLOGIC; TRANSFECTION;

EID: 0034501889     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(00)00190-7     Document Type: Conference Paper

References (26)

1. Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells
2. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor
3. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits
4. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules
5. + T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer
6. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C
7. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
8. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells
9. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9
10. Tap-and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide
11. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences
12. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
13. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
14. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E
15. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G-derived nonamer
16. Description of a new HLA-E (E*01031) allele and its frequency in the Spanish population
17. Population genetic studies of HLA-E: Evidence for selection
18. Polymorphism in the human class I MHC locus HLA-E in Japanese
19. Polymorphism at the HLA-E locus predates most HLA-A and -B polymorphism
20. 2-microglobulin and allelic differences
21. A new HLA-linked T cell membrane molecule, related to the beta chain of the clonotypic receptor, is associated with T3
22. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I α3 domain
23. Cutting edge: The human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis
24. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts
25. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
26. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells